| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615294 | Journal of Clinical Lipidology | 2016 | 22 Pages |
Abstract
Substitution of SFA with PUFA in patients with MetS is associated with greater reductions in TG and improvement in endothelial function than MUFA that is independent of weight loss. These preliminary findings raise the possibility that PUFA may be the unsaturated fat of choice to reduce cardiometabolic risk in patients with MetS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael MD, John D. MD, PhD, Laura DNP, Aimee BA, Jeffrey BA, Patrick BA, Kathy RD, Andrew P. MD,